Journal of Clinical Sciences

: 2021  |  Volume : 18  |  Issue : 2  |  Page : 73-

Leveraging on the faculty of clinical sciences capacity on cancer research

Adesoji O Ademuyiwa 
 Department of Surgery, Paediatric Surgery Unit, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria

Correspondence Address:
Prof. Adesoji O Ademuyiwa
Departement of Surgery, Faculty of Clinicial Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos

How to cite this article:
Ademuyiwa AO. Leveraging on the faculty of clinical sciences capacity on cancer research.J Clin Sci 2021;18:73-73

How to cite this URL:
Ademuyiwa AO. Leveraging on the faculty of clinical sciences capacity on cancer research. J Clin Sci [serial online] 2021 [cited 2021 May 17 ];18:73-73
Available from:

Full Text

Cancers remains one of the major causes of mortality in modern health-care delivery. Breast and cervical cancers in women and prostatic and lung cancers in male are major causes of death and morbidity. Our affiliated teaching hospital through the Nigeria Sovereign Investment Authority and Lagos University Teaching Hospital (NSIA-LUTH) collaboration has a dedicated radio-oncology center built at a cost of over 10 million dollars. Another philanthropist has donated a 4-storey building to take care of cancer-related diseases. The NSIA-LUTH Cancer center is one of the most sophisticated in Africa and certainly the best in West Africa as of now. These resources are scarce and should encourage researchers from our faculty to leverage on cutting edge cancer research that will impact clinical outcomes.

Further, with such resources, faculty members can attract grants for training other African countries, especially in the West African subregion and have exchange programs that could evolve into a Masters' degree-awarding program or even a PhD program. Moreover, opportunities abound to work together will distinguished researchers in Basic Medical Sciences to unravel many gaps in our understanding of cancer etiopathogenesis.

There are very interesting articles on cancer and cancer-related research in this edition of the Journal of Clinical Sciences. Ayandipo et al. from the University College Hospital in Ibadan, Nigeria, reported the largest series of gastrointestinal stromal tumors (GIST) from Africa in this edition of the journal.[1] Their study shows the clinicopathologic characteristics of GIST in African population is similar to those reported in other populations across the globe.

On the other hand, Akinsete et al. investigated the complications arising from the use of chemotherapy in a cohort of pediatric oncology patients.[2] They conclude that gastrointestinal complications are the most common and awareness of this finding and making available medications to prevent severity of these complications will improve tolerance of the chemotherapeutic agents.

Finally, Ajani et al. report their experience of male breast cancer over a decade.[3] They conclude that male breast cancer is rare and accounts for 1.7% of all cancers in their center, with invasive ductal carcinoma being the most common. More than 85% occur above the age of 40 years with the peak decade of incidence being 71–80 years accounting for 31% of cases.

There are other equally interesting articles including a case report that will make this edition of the journal a cherished archival material.

Happy reading


1Ayandipo OO, Ajagbe OA, Ogun GO, Adegoke OO, Adepoju OJ, Rahman A, et al. Gastrointestinal stromal tumor experience in a surgical oncological unit in sub-Sahara Africa. J Clin Sci 2021;18:98-102.
2Akinsete AM, Fakile UO, Nwobi EI. Pattern of postchemotherapy-associated complications in a pediatric oncology service in Lagos. J Clin Sci 2021;18:103-8.
3Ajani MA, Odetola SS, Awosusi BL, Fatunla EO, Salami AA. Histopathological analysis of male breast cancer in Southwestern Nigeria: A single-center retrospective study. J Clin Sci 2021;18:113-6.